Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

21 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Correction: Musumeci et al. Intranasal Administration of a TRAIL Neutralizing Monoclonal Antibody Adsorbed in PLGA Nanoparticles and NLC Nanosystems: An In Vivo Study on a Mouse Model of Alzheimer's Disease. Biomedicines 2022, 10, 985.
Musumeci T, Di Benedetto G, Carbone C, Bonaccorso A, Amato G, Lo Faro MJ, Burgaletto C, Puglisi G, Bernardini R, Cantarella G. Musumeci T, et al. Among authors: burgaletto c. Biomedicines. 2024 Oct 25;12(11):2447. doi: 10.3390/biomedicines12112447. Biomedicines. 2024. PMID: 39595214 Free PMC article.
Immune responses to oligomeric α-synuclein in Parkinson's disease peripheral blood mononuclear cells.
Vega-Benedetti AF, Porcedda C, Ercoli T, Fusco G, Burgaletto C, Pillai R, Palmas F, Cantone AF, Angius F, Solla P, De Simone A, Cantarella G, Giallongo C, Sogos V, Defazio G, Carta AR. Vega-Benedetti AF, et al. Among authors: burgaletto c. J Neurol. 2024 Sep;271(9):5916-5929. doi: 10.1007/s00415-024-12554-3. Epub 2024 Jul 10. J Neurol. 2024. PMID: 38985290 Free PMC article.
A web-based scoping review assessing the influence of smoking and smoking cessation on antidiabetic drug meabolism: implications for medication efficacy.
Bellanca CM, Augello E, Di Benedetto G, Burgaletto C, Cantone AF, Cantarella G, Bernardini R, Polosa R; DiaSmokeFree Working Group. Bellanca CM, et al. Among authors: burgaletto c. Front Pharmacol. 2024 Jun 18;15:1406860. doi: 10.3389/fphar.2024.1406860. eCollection 2024. Front Pharmacol. 2024. PMID: 38957391 Free PMC article. Review.
Pharmacological enhancement of cholinergic neurotransmission alleviates neuroinflammation and improves functional outcomes in a triple transgenic mouse model of Alzheimer's disease.
Munafò A, Cantone AF, Di Benedetto G, Torrisi SA, Burgaletto C, Bellanca CM, Gaudio G, Broggi G, Caltabiano R, Leggio GM, Bernardini R, Cantarella G. Munafò A, et al. Among authors: burgaletto c. Front Pharmacol. 2024 Mar 26;15:1386224. doi: 10.3389/fphar.2024.1386224. eCollection 2024. Front Pharmacol. 2024. PMID: 38595916 Free PMC article.
TRAIL-R Deficient Mice Are Protected from Neurotoxic Effects of Amyloid-β.
Di Benedetto G, Burgaletto C, Serapide MF, Caltabiano R, Munafò A, Bellanca CM, Di Mauro R, Bernardini R, Cantarella G. Di Benedetto G, et al. Among authors: burgaletto c. Int J Mol Sci. 2022 Oct 1;23(19):11625. doi: 10.3390/ijms231911625. Int J Mol Sci. 2022. PMID: 36232931 Free PMC article.
Intranasal Administration of a TRAIL Neutralizing Monoclonal Antibody Adsorbed in PLGA Nanoparticles and NLC Nanosystems: An In Vivo Study on a Mouse Model of Alzheimer's Disease.
Musumeci T, Di Benedetto G, Carbone C, Bonaccorso A, Amato G, Lo Faro MJ, Burgaletto C, Puglisi G, Bernardini R, Cantarella G. Musumeci T, et al. Among authors: burgaletto c. Biomedicines. 2022 Apr 23;10(5):985. doi: 10.3390/biomedicines10050985. Biomedicines. 2022. PMID: 35625722 Free PMC article.
Repurposing Pomalidomide as a Neuroprotective Drug: Efficacy in an Alpha-Synuclein-Based Model of Parkinson's Disease.
Palmas MF, Ena A, Burgaletto C, Casu MA, Cantarella G, Carboni E, Etzi M, De Simone A, Fusco G, Cardia MC, Lai F, Picci L, Tweedie D, Scerba MT, Coroneo V, Bernardini R, Greig NH, Pisanu A, Carta AR. Palmas MF, et al. Among authors: burgaletto c. Neurotherapeutics. 2022 Jan;19(1):305-324. doi: 10.1007/s13311-022-01182-2. Epub 2022 Jan 24. Neurotherapeutics. 2022. PMID: 35072912 Free PMC article.
21 results